Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Raymond I. Cruz, Francisco J. Hernandez-Ilizaliturri, Scott Olejniczak, George Deeb, Joy Knight, Paul Wallace, Beth L. Thurberg, William Kennedy & Myron S. Czuczman. (2007) CD52 over-expression affects rituximab-associated complement-mediated cytotoxicity but not antibody-dependent cellular cytotoxicity: Preclinical evidence that targeting CD52 with alemtuzumab may reverse acquired resistance to rituximab in non-Hodgkin lymphoma. Leukemia & Lymphoma 48:12, pages 2424-2436.
Read now
Read now
Giovanni D'Arena, Nicola Di Renzo, Maura Brugiatelli, Maria L. Vigliotti & Michael J. Keating. (2003) Biological and Clinical Heterogeneity of B-cell Chronic Lymphocytic Leukemia. Leukemia & Lymphoma 44:2, pages 223-228.
Read now
Read now
Articles from other publishers (5)
Carsten Zwick, Klaus-Dieter Preuss, Boris Kubuschok, Gerhard Held, Manfred Ahlgrimm, Joerg Bittenbring, Joerg Schubert, Frank Neumann & Michael Pfreundschuh. (2009) Analysis of the antibody repertoire of patients with mantle cell lymphoma directed against mantle cell lymphoma-associated antigens. Annals of Hematology 88:10, pages 999-1003.
Crossref
Crossref
Martin Klabusay, Vera Sukova, Petr Coupek, Yvona Brychtova & Jiri Mayer. (2007)
Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B‐lymphocytes, CD 34
+
cells and tumor cells of patients with chronic B‐cell lymphoproliferative diseases
. Cytometry Part B: Clinical Cytometry 72B:5, pages 363-370.
Crossref
Crossref
Shih-Sung Chuang, Wan-Ting Huang, Pin-Pen Hsieh, Hui-Hwa Tseng, Elias Campo, Dolors Colomer, Hongtao Ye, Chin-Li Lu, Hui-Mei Chang, Chi-Yi Cho, Shih-Hung Huang, Yin-Che Lu & Jiann-Der Wu. (2006) Mantle cell lymphoma in Taiwan: Clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2. Pathology International 56:8, pages 440-448.
Crossref
Crossref
D. Decaudin. (2004) Lymphome du manteau : un modèle biologique et clinique. EMC - Hématologie 1:3, pages 69-82.
Crossref
Crossref
Paul Moreton & Peter Hillmen. (2003) Alemtuzumab therapy in B-cell lymphoproliferative disorders. Seminars in Oncology 30:4, pages 493-501.
Crossref
Crossref